Skip to content
Mon, Oct 20, 2025
  • Twitter
  • Facebook
  • LinkedIn
  • Instagram
  • YouTube
Zocto

Zocto

Healthcare & wellness News Portal

  • Interviews & ProfilesDoctor & Specialist Interviews
  • Health NewsHealth News
  • Health Tips & AdviceHealth Tips & Advice
  • Healthcare Events & ConferencesHealthcare Events & Conferences
  • Healthcare Startups & InnovationsHealthcare Startups & Innovations
  • Healthcare TechnologyHealthcare Technology
  • Patient & Caregiver ResourcesPatient & Caregiver Resources
  • Pharmaceuticals & Healthcare ProductsPharmaceuticals & Healthcare Products
  • Healthcare Policy & EconomyHealthcare Policy & Economy
  • Workout
  • Lifestyle & Well-beingLifestyle & Well-being

Category: Chronic Conditions

Chronic Conditions

Cipla has introduced “CipAir,” a mobile application designed to facilitate early screening for asthma in India. Initially available on Android, the app aims to improve diagnosis and treatment accessibility for asthma patients.

Cipla has introduced “CipAir,” a mobile application designed to facilitate early screening for asthma in India. Initially available on Android, the app aims to improve diagnosis and treatment accessibility for asthma patients.

CipAir: Your mobile ally for asthma screening in India!

Cipla launches mobile app for asthma screening

Cipla launches mobile app for asthma screening

Breathe Easy: Cipla’s New App for Asthma Screening!

Intas Pharma acquires Udenyca biosimilar brand

Intas Pharma acquires Udenyca biosimilar brand

Intas Pharma Celebrates Udenyca Acquisition Success!

Government proposes extension for revised Schedule M compliance

Government proposes extension for revised Schedule M compliance

Cheers to More Time: Schedule M Compliance Extended!

Cipla’s Q2FY25 financial performance

Cipla’s Q2FY25 financial performance

Cipla Shines Bright in Q2FY25: A Stellar Financial Surge!

AstraZeneca Pharma India reports Q2FY25 financials

AstraZeneca Pharma India reports Q2FY25 financials

AstraZeneca India Soars: Q2FY25 Financials Shine Bright!

Indian pharmaceutical market registers over 6% growth in October 2024

Indian pharmaceutical market registers over 6% growth in October 2024

Indian Pharma Shines: October Growth Surges Past 6%!

Novo Nordisk anticipates high demand for obesity drugs in India

Novo Nordisk anticipates high demand for obesity drugs in India

Novo Nordisk Eyes Rising Demand for Obesity Meds in India!

Biocon Biologics plans to launch three biosimilars globally

Biocon Biologics plans to launch three biosimilars globally

Biocon Biologics set to unveil trio of biosimilars!

Sun Pharma’s Q2FY25 profit growth

Sun Pharma’s Q2FY25 profit growth

Sun Pharma Shines Bright: Q2FY25 Profit Soars!

Posts pagination

Previous 1 … 97 98 99 … 103 Next
  • About
  • Team
  • Mission & Vision
  • Get Published
  • Contact Us
  • User Terms
  • Privacy Policy
  • Content Disclaimer
  • Cancellation & Refund Policy
  • Shipping Policy
  • Pricing Policy
  • Zocto certificate of excellence
Subscribe to our Newsletters
Copyright © 2025 Zocto | Newspulse Magazine by Ascendoor | Powered by WordPress.